Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Moe Hayasaka"'
Autor:
Masanori Mizuno, Takamasa Ichijo, Kei Murayama, Takuya Fushimi, Ayano Inui, Moe Hayasaka, Kayoko Ikehara, Mariko Higa
Publikováno v:
An Official Journal of the Japan Primary Care Association. 45:126-131
Autor:
Mai Hijikata, Ruma Eto, Genki Sato, Kaoru Yamashita, Ayako Fuchigami, Takamasa Ichijo, Mariko Higa, Miki Kawai, Moe Hayasaka
Publikováno v:
Journal of the Endocrine Society
It is well known the primary aldosteronism (PA) is most common endocrinological hypertension and accounted for 10% among all hypertension population, and it develops cardiovascular disease more frequently than blood pressure matched essential hyperte
Autor:
Kenzaburo Oda, Takamasa Ichijo, Daisuke Kato, Ayana Hashimoto, Moe Hayasaka, Kaoru Yamashita, Ayami Ueda, Mai Hijikata, Mariko Higa
Publikováno v:
Diabetes. 67
Increasing evidence supports a more prominent role for postprandial glucose (PPG) regulation in the management of type 2 diabetes. Viscous dietary fibers including oat and barley β-glucan are one of the most effective classes of functional food ingr
Autor:
Eiko Yoshida, Shiori Abe, Mari Shimizu, Tomoko Okuyama, Yu Togashi, Jun Shirakawa, Yuka Horigome, Yasuo Terauchi, Takayuki Tuno, Moe Hayasaka, Masahiro Fuse
Publikováno v:
Endocrinology. 155:2102-2111
The IGF-1 receptor has become a therapeutic target for the treatment of cancer. The efficacy of OSI-906 (linstinib), a dual inhibitor of IGF-1 receptor and insulin receptor, for solid cancers has been examined in clinical trials. The effects of OSI-9